Zacks Research Estimates MKS’s Q2 Earnings (NASDAQ:MKSI)

MKS Inc. (NASDAQ:MKSI) – Zacks Research issued their Q2 2026 EPS estimates for MKS in a report issued on Wednesday, May 27th. Zacks Research analyst Team anticipates that the scientific and technical instruments company will post earnings per share of $2.92 for the quarter. The consensus estimate for MKS’s current full-year earnings is $11.54 per share. Zacks Research also issued estimates for MKS’s Q3 2026 earnings at $3.22 EPS, Q4 2026 earnings at $3.42 EPS, FY2026 earnings at $11.86 EPS, Q1 2027 earnings at $3.53 EPS, Q2 2027 earnings at $3.81 EPS, Q3 2027 earnings at $3.95 EPS, Q4 2027 earnings at $3.72 EPS, FY2027 earnings at $15.00 EPS, Q1 2028 earnings at $4.68 EPS and FY2028 earnings at $18.24 EPS.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.00 by $0.30. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. MKS had a net margin of 8.06% and a return on equity of 21.49%. MKS’s revenue was up 15.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.71 earnings per share. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS.

A number of other equities analysts also recently weighed in on MKSI. The Goldman Sachs Group reaffirmed a “sell” rating and set a $265.00 price target on shares of MKS in a research note on Thursday, May 7th. Wells Fargo & Company raised their target price on shares of MKS from $255.00 to $300.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. KeyCorp raised their target price on shares of MKS from $310.00 to $360.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. raised their target price on shares of MKS from $305.00 to $365.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Finally, Cantor Fitzgerald raised their target price on shares of MKS from $300.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $324.92.

MKS Stock Performance

NASDAQ:MKSI opened at $323.41 on Friday. The company has a quick ratio of 0.70, a current ratio of 1.11 and a debt-to-equity ratio of 0.94. The company has a market cap of $21.84 billion, a P/E ratio of 67.66, a P/E/G ratio of 1.19 and a beta of 1.98. MKS has a fifty-two week low of $80.22 and a fifty-two week high of $339.00. The firm’s 50 day moving average is $274.66 and its two-hundred day moving average is $223.75.

Institutional Investors Weigh In On MKS

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Norges Bank acquired a new position in MKS during the 4th quarter worth $147,453,000. Southpoint Capital Advisors LP acquired a new position in MKS during the 4th quarter worth $95,880,000. Westfield Capital Management Co. LP grew its holdings in MKS by 159.7% during the 4th quarter. Westfield Capital Management Co. LP now owns 839,773 shares of the scientific and technical instruments company’s stock worth $134,196,000 after acquiring an additional 516,409 shares in the last quarter. Millennium Management LLC grew its holdings in MKS by 9,165.9% during the 3rd quarter. Millennium Management LLC now owns 446,248 shares of the scientific and technical instruments company’s stock worth $55,232,000 after acquiring an additional 441,432 shares in the last quarter. Finally, Rafferty Asset Management LLC grew its holdings in MKS by 63.4% during the 2nd quarter. Rafferty Asset Management LLC now owns 878,114 shares of the scientific and technical instruments company’s stock worth $87,249,000 after acquiring an additional 340,645 shares in the last quarter. Hedge funds and other institutional investors own 99.79% of the company’s stock.

Insider Activity

In related news, CFO Ramakumar Mayampurath sold 8,810 shares of MKS stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $315.48, for a total transaction of $2,779,378.80. Following the sale, the chief financial officer owned 1 shares of the company’s stock, valued at $315.48. The trade was a 99.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph B. Donahue sold 2,100 shares of MKS stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $327.95, for a total transaction of $688,695.00. Following the sale, the director directly owned 10,033 shares in the company, valued at $3,290,322.35. This trade represents a 17.31% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 56,723 shares of company stock worth $17,830,688 over the last three months. 0.57% of the stock is currently owned by corporate insiders.

MKS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, June 3rd will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, June 3rd. This represents a $1.00 annualized dividend and a yield of 0.3%. MKS’s payout ratio is 20.92%.

Key Headlines Impacting MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Zacks Research raised its outlook across multiple future periods for MKS, with estimates pointing to solid earnings growth from $11.86 per share in FY2026 to $15.00 in FY2027 and $18.24 in FY2028, reinforcing the market’s growth narrative for the stock.
• Positive Sentiment: The company’s latest quarterly report topped expectations, with MKS posting $2.30 EPS on $1.08 billion in revenue, both above estimates, and management guided Q2 2026 EPS to $2.60-$3.20, which supports investor confidence.
• Neutral Sentiment: MKS recently announced a quarterly dividend of $0.25 per share, payable June 12, which is supportive but not large enough to be a major stock driver on its own.
• Negative Sentiment: Several insiders, including EVP David Philip Henry and Director Joseph Donahue, sold shares this week under pre-arranged plans, which can create a modest headwind for sentiment even if the sales were not necessarily a bearish signal.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.